Condition: Colorectal Cancer · Sponsor: Ding Ke-Feng
NCRCC study is a national prospective cohort study including colorectal cancer screening population and stage Ⅰ-Ⅳ colorectal cancer patients.
This description comes directly from the study's public registry record.
Ke-feng Ding, PhD/MD · 86-571-87784827 · dingkefeng@zju.edu.cn
Always discuss trial participation with your own doctor first.
| Second Affiliated Hospital Zhejiang University College of Medicine | Hangzhou, Zhejiang, China | Recruiting |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Beijing, China | Recruiting |
| West China Hospital | Chengdu, China | Recruiting |
| Sun Yat-sen University | Guangzhou, China | Recruiting |
| Shanghai Zhongshan Hospital | Shanghai, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04074538